Skip to main content
. Author manuscript; available in PMC: 2021 Jun 16.
Published in final edited form as: Curr Allergy Asthma Rep. 2020 Jun 16;20(9):42. doi: 10.1007/s11882-020-00935-3

Figure 2. Heterogeneity in adjuvant activity associated with HDE.

Figure 2.

A) Timeline of asthma model, including allergic sensitization to OVA using different HDEs as the adjuvant, followed by challenge with OVA alone. B, C) Eosinophils (B) and neutrophils (C) in BALF following OVA challenge of mice previously sensitized using different samples of HDE. Note that each HDE is color-coded to allow comparisons in their ability to prime responses leading to eosinophilic and neutrophilic inflammation, respectively.